YUMA REGIONAL MEDICAL CENTER
- Type
- Teaching hospital
- Where
- YUMA, AZ
- Medicare CCN
- 030013
- Received
- $148,360 in 91 records, 2019 ($35,283 general, $113,076 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: YUMA REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Plan sponsor: YUMA REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Federal award recipient: YUMA REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: YUMA REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Nonprofit: YUMA REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Trademark owner: Yuma Regional Medical Center Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 24 | $35,283 |
| 2019 | Research payment | 67 | $113,076 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Eli Lilly and Company | 4 | $40,609 | 2019 |
| Surmodics, Inc. | 44 | $36,823 | 2019 |
| GenMark Diagnostics, Inc. | 1 | $26,593 | 2019 |
| Boston Scientific Corporation | 13 | $16,658 | 2019 |
| Incyte Corporation | 2 | $7,058 | 2019 |
| Spectrum Pharmaceuticals Inc. | 2 | $6,082 | 2019 |
| Cordis Corporation | 2 | $5,844 | 2019 |
| AngioDynamics, Inc. | 3 | $4,200 | 2019 |
| Stryker Corporation | 1 | $1,562 | 2019 |
| Arrow International, Inc. | 2 | $1,190 | 2019 |
| Vitalant | 13 | $1,108 | 2019 |
| GE HEALTHCARE | 1 | $374 | 2019 |
| Siemens Medical Solutions USA, Inc. | 1 | $136 | 2019 |
| Masimo Corporation | 1 | $81 | 2019 |
| Olympus America Inc. | 1 | $36 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 67 | $113,076 |
| Honoraria | 1 | $26,593 |
| Education | 4 | $4,281 |
| Gift | 4 | $2,788 |
| Space rental or facility fees (teaching hospital only) | 13 | $1,108 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 1 | $374 |
| Charitable Contribution | 1 | $136 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | Stryker Corporation | $1,562 | Gift | Cash or cash equivalent | NONE Device, NONE | 2019 | |
| 2019-12-31 | AngioDynamics, Inc. | $1,400 | Education | In-kind items and services | Celerity Device, Vascular Access | 2019 | |
| 2019-12-31 | AngioDynamics, Inc. | $1,400 | Education | In-kind items and services | Celerity Device, Vascular Access | 2019 | |
| 2019-12-31 | AngioDynamics, Inc. | $1,400 | Education | In-kind items and services | Celerity Device, Vascular Access | 2019 | |
| 2019-12-31 | Siemens Medical Solutions USA, Inc. | $136 | Charitable Contribution | In-kind items and services | 2019 | ||
| 2019-12-31 | Masimo Corporation | $81 | Education | In-kind items and services | SedLine Device, Devices | 2019 | |
| 2019-12-26 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-12-17 | Surmodics, Inc. | $1,000 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-12-17 | Surmodics, Inc. | $572 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-12-17 | Surmodics, Inc. | $500 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-12-17 | Surmodics, Inc. | $500 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-12-17 | Surmodics, Inc. | $500 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-12-16 | Eli Lilly and Company | $13,000 | Research payment | Cash or cash equivalent | A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD | 2019 | |
| 2019-12-16 | Boston Scientific Corporation | $150 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | APPRAISE ATP | 2019 |
| 2019-12-02 | Boston Scientific Corporation | $3,511 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | APPRAISE ATP | 2019 |
| 2019-12-02 | Boston Scientific Corporation | $1,022 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | APPRAISE ATP | 2019 |
| 2019-12-02 | Boston Scientific Corporation | $900 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | APPRAISE ATP | 2019 |
| 2019-12-02 | Boston Scientific Corporation | $540 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | APPRAISE ATP | 2019 |
| 2019-12-02 | Boston Scientific Corporation | $400 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | APPRAISE ATP | 2019 |
| 2019-11-21 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-10-25 | Surmodics, Inc. | $1,165 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-10-24 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-10-05 | Eli Lilly and Company | $182 | Research payment | In-kind items and services | A MULTICENTER, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY OF ABEMACICLIB, A CDK4 AND 6 INHIBITOR, IN COMBINATION WITH FULVE | 2019 | |
| 2019-10-03 | GenMark Diagnostics, Inc. | $26,593 | Honoraria | In-kind items and services | ePlex Device, multiplex molecular testing system | 2019 | |
| 2019-09-26 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-09-16 | Boston Scientific Corporation | $1,065 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | APPRAISE ATP | 2019 |
| 2019-09-16 | Boston Scientific Corporation | $802 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | IMPERIAL | 2019 |
| 2019-08-30 | Eli Lilly and Company | $27,090 | Research payment | Cash or cash equivalent | A MULTICENTER, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY OF ABEMACICLIB, A CDK4 AND 6 INHIBITOR, IN COMBINATION WITH FULVE | 2019 | |
| 2019-08-22 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-08-08 | Surmodics, Inc. | $1,606 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-08-08 | Surmodics, Inc. | $1,606 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-08-08 | Surmodics, Inc. | $1,373 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-08-08 | Surmodics, Inc. | $1,373 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-08-08 | Surmodics, Inc. | $1,300 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-08-08 | Surmodics, Inc. | $1,300 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-08-08 | Surmodics, Inc. | $1,165 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-08-08 | Surmodics, Inc. | $630 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-07-25 | Arrow International, Inc. | $790 | Gift | Cash or cash equivalent | CATHETER - ARROW Device, Vascular | 2019 | |
| 2019-07-25 | Arrow International, Inc. | $400 | Gift | Cash or cash equivalent | CATHETER - ARROW Device, Vascular | 2019 | |
| 2019-07-25 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-07-17 | Surmodics, Inc. | $9,000 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-07-17 | Surmodics, Inc. | $572 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-07-17 | Surmodics, Inc. | $572 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-07-17 | Surmodics, Inc. | $557 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-06-20 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-06-14 | Boston Scientific Corporation | $2,217 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | APPRAISE ATP | 2019 |
| 2019-05-23 | Surmodics, Inc. | $630 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-05-23 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-05-06 | Boston Scientific Corporation | $3,833 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | APPRAISE ATP | 2019 |
| 2019-05-03 | Cordis Corporation | $3,925 | Research payment | Cash or cash equivalent | FlexStent Femoropopliteal Self Expanding Stent System Device, Cardiovascular | Cordis OPEN | 2019 |
| 2019-05-03 | Cordis Corporation | $1,919 | Research payment | Cash or cash equivalent | FlexStent Femoropopliteal Self Expanding Stent System Device, Cardiovascular | Cordis OPEN | 2019 |
| 2019-04-29 | Incyte Corporation | $2,961 | Research payment | Cash or cash equivalent | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 | |
| 2019-04-29 | GE HEALTHCARE | $374 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-04-25 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-04-22 | Boston Scientific Corporation | $1,500 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | IMPERIAL | 2019 |
| 2019-03-23 | Olympus America Inc. | $36 | Gift | In-kind items and services | Olympus VC Products Device, Urology/Gynecology Products | 2019 | |
| 2019-03-22 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-03-18 | Boston Scientific Corporation | $315 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | APPRAISE ATP | 2019 |
| 2019-03-07 | Surmodics, Inc. | $4,000 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $1,300 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $250 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-03-07 | Surmodics, Inc. | $100 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2019 |
| 2019-02-22 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-02-21 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-02-05 | Incyte Corporation | $4,096 | Research payment | Cash or cash equivalent | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 | |
| 2019-02-04 | Boston Scientific Corporation | $400 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | APPRAISE ATP | 2019 |
| 2019-01-24 | Vitalant | $85 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-01-18 | Spectrum Pharmaceuticals Inc. | $4,107 | Research payment | Cash or cash equivalent | SPI-GCF-301 | 2019 | |
| 2019-01-18 | Spectrum Pharmaceuticals Inc. | $1,975 | Research payment | Cash or cash equivalent | SPI-GCF-301 | 2019 | |
| 2019-01-02 | Eli Lilly and Company | $336 | Research payment | In-kind items and services | A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Yuma, AZ, county Yuma County, AZ, state Arizona; placed by its city name.
| Measure | Place (city or town) Yuma, AZ | County Yuma County, AZ | State Arizona |
|---|---|---|---|
| Population B01003 | 100,139 | 211,741 | 7,378,838 |
| Population, 2020 census P1 | 95,548 | 203,881 | 7,151,502 |
| Median age B01002 | 33.1 | 36.1 | 39.0 |
| Under 18 B01001 | 25.5% | 24.6% | 21.6% |
| 65 and over B01001 | 17.6% | 20.7% | 18.9% |
| Households B11001 | 39,110 | 79,341 | 2,856,081 |
| Foreign born B05002 | 19.5% | 25.1% | 13.0% |
| Median household income B19013 | $65,482 | $62,876 | $79,964 |
| Median family income B19113 | $73,504 | $71,136 | $95,980 |
| Per capita income B19301 | $33,951 | $30,204 | $42,503 |
| Poverty rate B17001 | 15.5% | 15.6% | 12.5% |
| Unemployment rate B23025 | 6.3% | 6.9% | 5.1% |
| Civilian labor force B23025 | 42,858 | 83,296 | 3,598,840 |
| Mean commute (minutes) B08013 | 18.4 | 21.3 | 25.4 |
| Bachelor's degree or higher B15003 | 20.9% | 16.8% | 33.3% |
| Housing units B25001 | 44,663 | 95,200 | 3,192,839 |
| Owner-occupied B25003 | 66.8% | 71.0% | 67.4% |
| Renters B25003 | 33.2% | 29.0% | 32.6% |
| Median home value B25077 | $230,000 | $217,800 | $394,500 |
| Median gross rent B25064 | $1,114 | $993 | $1,543 |
| White, not Hispanic B03002 | 31.2% | 29.0% | 52.6% |
| Black B03002 | 1.9% | 1.5% | 4.4% |
| Hispanic or Latino B03002 | 60.8% | 64.9% | 31.4% |
| Asian B03002 | 1.7% | 1.0% | 3.5% |
| American Indian and Alaska Native B03002 | 0.7% | 0.8% | 3.2% |
Economy now FRED unemployment 4.9% in Sep 2026 (4.4% a year earlier); per capita personal income $68,373 in 2025, up 31% in five years (+5.7% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Yuma, AZ.
Comments